Generalized Anxiety Disorder Gad clinical trials

Explore recruiting generalized anxiety disorder gad clinical trials.

Recruiting generalized anxiety disorder gad studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Generalized Anxiety Disorder Gad trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to examine the effects of oral NTX-1955 on the brain in healthy adults.

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

CO2 challenge study of NTX-1955 in healthy participants

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study (Part A) with a 40 Week Open-Label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults with Generalized Anxiety Disorder - Panorama

France, Czechia, Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 as Monotherapy Treatment in Patients with Generalized Anxiety Disorder Who Have Had Inadequate Response to Generalized Anxiety Disorder Treatment

Poland, Slovakia, Bulgaria, Czechia, Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Long Covid (LC)-Revitalize - A Long Covid Repurposed Drug Study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Generalized Anxiety Disorder Gad trials by city

Generalized Anxiety Disorder Gad in Toronto Generalized Anxiety Disorder Gad in Vancouver Generalized Anxiety Disorder Gad in Montreal Generalized Anxiety Disorder Gad in Calgary Generalized Anxiety Disorder Gad in Edmonton Generalized Anxiety Disorder Gad in Ottawa Generalized Anxiety Disorder Gad in Winnipeg Generalized Anxiety Disorder Gad in Quebec City Generalized Anxiety Disorder Gad in Hamilton Generalized Anxiety Disorder Gad in Kitchener Generalized Anxiety Disorder Gad in London Generalized Anxiety Disorder Gad in Halifax Generalized Anxiety Disorder Gad in New York Generalized Anxiety Disorder Gad in Los Angeles Generalized Anxiety Disorder Gad in Chicago Generalized Anxiety Disorder Gad in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease